BIB vs IBB

ProShares Ultra NASDAQ Biotechnology against iShares Biotechnology ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
55%
208 shared positions
Fee gap
51 bp
IBB is cheaper
1-year return gap
31.5 pts
BIB is ahead
Larger fund
IBB
$11.0B

Side by side

BIBIBB
FundProShares Ultra NASDAQ BiotechnologyiShares Biotechnology ETF
IssuerProSharesiShares
CategoryLeveraged EquityBiotech & Health Innovation
Expense ratio0.95%0.44%
Assets$96M$11.0B
Average daily dollar volume$842K$341M
ListedApr 6, 2010Feb 5, 2001
FrenzyCap score4482
1-month return−2.1%+0.4%
3-month return+15.8%+11.9%
Year to date+43.8%+25.4%
1-year return+66.7%+35.2%
30-day volatility50.7%25.5%
Worst drawdown, 1 year−17.9%−9.7%
Trailing 12-month yield0.20%0.16%
Holdings256248
Top 10 weight157.8%51.1%
Look-through P/E——
Holdings vs fair value+3.4%+0.4%
Holdings above 200-day average78%81%
Net flow, latest 3 reported months−$14M thru May 2026−$43M thru Jun 2026
30-day implied volatility49.1%25.4%
Holdings as ofas of Oct 21, 2026issuer dataas of Oct 20, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

55% of BIB · 92% of IBB
HoldingBIBIBB
GILD5.12%8.49%
AMGN4.97%8.10%
VRTX4.70%7.50%
MRNA3.92%6.21%
REGN3.25%5.62%
ILMN1.70%2.83%
RVMD1.66%2.66%
BIIB1.42%2.50%
ALNY1.20%2.16%
ROIV1.06%1.28%
ARGX0.97%3.39%
UTHR0.96%1.61%
INCY0.92%1.65%
INSM0.82%1.44%
MEDP0.74%0.98%
EXEL0.64%1.08%
ASND0.59%1.01%
NBIX0.57%1.00%
HALO0.56%0.98%
ONC0.55%2.27%
BBIO0.54%0.83%
TEM0.47%0.50%
BMRN0.43%0.76%
MDGL0.42%0.71%
BNTX0.42%0.61%

Sector mix of the stock holdings

SectorBIBIBBGap
Health Care58.3%95.4%−37.1%
Technology2.6%4.5%−1.9%
Materials0.0%0.0%−0.0%

More: full overlap table · BIB holdings · IBB holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.